- Home
- TXMD vs ABVE Comparison
TXMD vs ABVE Comparison
Compare TXMD & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- ABVE
- Stock Information
- Founded
- TXMD 2008
- ABVE 2019
- Country
- TXMD United States
- ABVE Canada
- Employees
- TXMD N/A
- ABVE N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- ABVE Packaged Foods
- Sector
- TXMD Health Care
- ABVE Consumer Staples
- Exchange
- TXMD Nasdaq
- ABVE Nasdaq
- Market Cap
- TXMD 12.8M
- ABVE 15.1M
- IPO Year
- TXMD N/A
- ABVE N/A
- Fundamental
- Price
- TXMD $1.06
- ABVE $0.60
- Analyst Decision
- TXMD
- ABVE
- Analyst Count
- TXMD 0
- ABVE 0
- Target Price
- TXMD N/A
- ABVE N/A
- AVG Volume (30 Days)
- TXMD 852.1K
- ABVE 311.2K
- Earning Date
- TXMD 11-12-2024
- ABVE 02-15-2025
- Dividend Yield
- TXMD N/A
- ABVE N/A
- EPS Growth
- TXMD N/A
- ABVE N/A
- EPS
- TXMD N/A
- ABVE N/A
- Revenue
- TXMD $1,596,000.00
- ABVE $275,376,450.00
- Revenue This Year
- TXMD $605.07
- ABVE N/A
- Revenue Next Year
- TXMD $1.11
- ABVE N/A
- P/E Ratio
- TXMD N/A
- ABVE N/A
- Revenue Growth
- TXMD N/A
- ABVE N/A
- 52 Week Low
- TXMD $0.70
- ABVE $0.34
- 52 Week High
- TXMD $2.75
- ABVE $4.07
- Technical
- Relative Strength Index (RSI)
- TXMD 44.74
- ABVE N/A
- Support Level
- TXMD $0.99
- ABVE N/A
- Resistance Level
- TXMD $1.14
- ABVE N/A
- Average True Range (ATR)
- TXMD 0.27
- ABVE 0.00
- MACD
- TXMD -0.00
- ABVE 0.00
- Stochastic Oscillator
- TXMD 20.69
- ABVE 0.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.